Although all valuations are speculative in nature,I believe Col’s is far more plausible than ValueAdd’s. $2/share is way under value in any way the pie is cut.
What if CF33 as a monotherapy outperforms the combination treatments? What if the OV completely disrupts existing treatments altogether? What if it is used as a vaccine? How long can the OV remain viable in the body? Could ppl require an annual / regular vaccine? How will potential combo treatments be split? 50/50, 80/20? The possibilities are vast. If CF33 reaches the heights we are all hoping, every government across the globe will want a piece of it. It will change humanity. Productivity, healthcare costs, quality of life, quality of relationships, no side effects.. the implications are mind-boggling.
In my eyes this company could well be a 100-bagger. I will not be selling at $2/share
- Forums
- ASX - By Stock
- IMU Target $2.00 - Not Ramping !!!
Although all valuations are speculative in nature,I believe...
- There are more pages in this discussion • 283 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
(20min delay)
|
|||||
Last
6.4¢ |
Change
-0.003(4.48%) |
Mkt cap ! $468.4M |
Open | High | Low | Value | Volume |
6.7¢ | 6.7¢ | 6.4¢ | $1.264M | 19.44M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
14 | 1346122 | 6.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.5¢ | 1462857 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
14 | 1346122 | 0.064 |
16 | 2329024 | 0.063 |
14 | 837807 | 0.062 |
17 | 1911194 | 0.061 |
42 | 2692371 | 0.060 |
Price($) | Vol. | No. |
---|---|---|
0.065 | 1462857 | 4 |
0.066 | 1286304 | 7 |
0.067 | 5615178 | 9 |
0.068 | 812301 | 11 |
0.069 | 659927 | 5 |
Last trade - 16.10pm 03/06/2024 (20 minute delay) ? |
|
|||||
Last
6.4¢ |
  |
Change
-0.003 ( 4.05 %) |
|||
Open | High | Low | Volume | ||
6.7¢ | 6.7¢ | 6.4¢ | 10056995 | ||
Last updated 15.59pm 03/06/2024 ? |
Featured News
IMU (ASX) Chart |